107 related articles for article (PubMed ID: 25492294)
1. [Comparative study on functional characters of MCF7 and HCC1937 cell lines in response to DNA damage].
Dong C; Zhang F; Zhao X; Guo G; Luo Y; Feng Z
Zhonghua Yu Fang Yi Xue Za Zhi; 2014 Sep; 48(9):809-14. PubMed ID: 25492294
[TBL] [Abstract][Full Text] [Related]
2. Ionizing radiation inhibits the PLK cell cycle gene in a G2 checkpoint-dependent manner.
Ree AH; Bratland A; Solberg Landsverk K; Fodstad O
Anticancer Res; 2004; 24(2B):555-62. PubMed ID: 15160994
[TBL] [Abstract][Full Text] [Related]
3. p53 is involved in clearance of ionizing radiation-induced RAD51 foci in a human colon cancer cell line.
Orre LM; Stenerlöw B; Dhar S; Larsson R; Lewensohn R; Lehtiö J
Biochem Biophys Res Commun; 2006 Apr; 342(4):1211-7. PubMed ID: 16516153
[TBL] [Abstract][Full Text] [Related]
4. p53 suppresses hyper-recombination by modulating BRCA1 function.
Dong C; Zhang F; Luo Y; Wang H; Zhao X; Guo G; Powell SN; Feng Z
DNA Repair (Amst); 2015 Sep; 33():60-9. PubMed ID: 26162908
[TBL] [Abstract][Full Text] [Related]
5. Functional characterization of a novel BRCA1-null ovarian cancer cell line in response to ionizing radiation.
DelloRusso C; Welcsh PL; Wang W; Garcia RL; King MC; Swisher EM
Mol Cancer Res; 2007 Jan; 5(1):35-45. PubMed ID: 17259345
[TBL] [Abstract][Full Text] [Related]
6. Differing effects of breast cancer 1, early onset (BRCA1) and ataxia-telangiectasia mutated (ATM) mutations on cellular responses to ionizing radiation.
Mamon HJ; Dahlberg W; Azzam EI; Nagasawa H; Muto MG; Little JB
Int J Radiat Biol; 2003 Oct; 79(10):817-29. PubMed ID: 14630541
[TBL] [Abstract][Full Text] [Related]
7. BRCA2 is required for ionizing radiation-induced assembly of Rad51 complex in vivo.
Yuan SS; Lee SY; Chen G; Song M; Tomlinson GE; Lee EY
Cancer Res; 1999 Aug; 59(15):3547-51. PubMed ID: 10446958
[TBL] [Abstract][Full Text] [Related]
8. Repression of mRNA for the PLK cell cycle gene after DNA damage requires BRCA1.
Ree AH; Bratland A; Nome RV; Stokke T; Fodstad Ø
Oncogene; 2003 Dec; 22(55):8952-5. PubMed ID: 14654792
[TBL] [Abstract][Full Text] [Related]
9. DNA damage induces p53-dependent BRCA1 nuclear export.
Feng Z; Kachnic L; Zhang J; Powell SN; Xia F
J Biol Chem; 2004 Jul; 279(27):28574-84. PubMed ID: 15087457
[TBL] [Abstract][Full Text] [Related]
10. Altered expression of proliferation-inducing and proliferation-inhibiting genes might contribute to acquired doxorubicin resistance in breast cancer cells.
Saleh EM; El-Awady RA; Abdel Alim MA; Abdel Wahab AH
Cell Biochem Biophys; 2009; 55(2):95-105. PubMed ID: 19593673
[TBL] [Abstract][Full Text] [Related]
11. Indole-3-carbinol activates the ATM signaling pathway independent of DNA damage to stabilize p53 and induce G1 arrest of human mammary epithelial cells.
Brew CT; Aronchik I; Hsu JC; Sheen JH; Dickson RB; Bjeldanes LF; Firestone GL
Int J Cancer; 2006 Feb; 118(4):857-68. PubMed ID: 16152627
[TBL] [Abstract][Full Text] [Related]
12. Cellular responses of BRCA1-defective and triple-negative breast cancer cells and in vitro BRCA1 interactions induced by metallo-intercalator ruthenium(II) complexes containing chloro-substituted phenylazopyridine.
Nhukeaw T; Temboot P; Hansongnern K; Ratanaphan A
BMC Cancer; 2014 Feb; 14():73. PubMed ID: 24507701
[TBL] [Abstract][Full Text] [Related]
13. Functional analysis of the p53 pathway in response to ionizing radiation in uveal melanoma.
Sun Y; Tran BN; Worley LA; Delston RB; Harbour JW
Invest Ophthalmol Vis Sci; 2005 May; 46(5):1561-4. PubMed ID: 15851551
[TBL] [Abstract][Full Text] [Related]
14. Synthetically Lethal BMN 673 (Talazoparib) Loaded Solid Lipid Nanoparticles for BRCA1 Mutant Triple Negative Breast Cancer.
Guney Eskiler G; Cecener G; Egeli U; Tunca B
Pharm Res; 2018 Sep; 35(11):218. PubMed ID: 30255456
[TBL] [Abstract][Full Text] [Related]
15. [DNA damage induces BRCA1 distribution alteration in prostate cancer cell lines].
Wang CY; Sun SK; Fu WJ; Song T; Cai W; Gao JP; Hong BF; Wang XX; Wang H
Zhonghua Nan Ke Xue; 2008 Aug; 14(8):685-9. PubMed ID: 18817338
[TBL] [Abstract][Full Text] [Related]
16. The carboxyl-terminal of BRCA1 is required for subnuclear assembly of RAD51 after treatment with cisplatin but not ionizing radiation in human breast and ovarian cancer cells.
Zhou C; Huang P; Liu J
Biochem Biophys Res Commun; 2005 Oct; 336(3):952-60. PubMed ID: 16165098
[TBL] [Abstract][Full Text] [Related]
17. Dissociation between cell cycle arrest and apoptosis can occur in Li-Fraumeni cells heterozygous for p53 gene mutations.
Delia D; Goi K; Mizutani S; Yamada T; Aiello A; Fontanella E; Lamorte G; Iwata S; Ishioka C; Krajewski S; Reed JC; Pierotti MA
Oncogene; 1997 May; 14(18):2137-47. PubMed ID: 9174049
[TBL] [Abstract][Full Text] [Related]
18. The Novel Ribonucleotide Reductase Inhibitor COH29 Inhibits DNA Repair In Vitro.
Chen MC; Zhou B; Zhang K; Yuan YC; Un F; Hu S; Chou CM; Chen CH; Wu J; Wang Y; Liu X; Smith DL; Li H; Liu Z; Warden CD; Su L; Malkas LH; Chung YM; Hu MC; Yen Y
Mol Pharmacol; 2015 Jun; 87(6):996-1005. PubMed ID: 25814515
[TBL] [Abstract][Full Text] [Related]
19. Differential sensitivity of BRCA1-mutated HCC1937 human breast cancer cells to microtubule-interfering agents.
Tassone P; Blotta S; Palmieri C; Masciari S; Quaresima B; Montagna M; D'Andrea E; Eramo OP; Migale L; Costanzo F; Tagliaferri P; Venuta S
Int J Oncol; 2005 May; 26(5):1257-63. PubMed ID: 15809716
[TBL] [Abstract][Full Text] [Related]
20. BRCA1-deficient breast cancer cell lines are resistant to MEK inhibitors and show distinct sensitivities to 6-thioguanine.
Gu Y; Helenius M; Väänänen K; Bulanova D; Saarela J; Sokolenko A; Martens J; Imyanitov E; Kuznetsov S
Sci Rep; 2016 Jun; 6():28217. PubMed ID: 27313062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
